Engineered gut bacteria match fecal transplants in small C difficile trial

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted ...

Idorsia reports new positive results with its breakthrough C. difficile vaccine – underscoring the unique potential of its glycan technology

High-dose cohort confirms the favorable safety profile and the dose-dependent immune response against Clostridioides ...
News Medical

Tufts researchers identify new vulnerabilities to combat persistent C. diff infections

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...
Hosted on MSN

Targeting a dangerous gut infection: Studies reveal how C diff behaves inside the body

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known as C. diff—are a serious and persistent problem for patients and hospitals ...
EurekAlert!

Novel vaccine protects against C. diff disease and recurrence

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

Idorsia Pharmaceuticals Ltd: Idorsia reports new positive results with its breakthrough C. difficile vaccine - underscoring the unique potential of its glycan technology

High-dose cohort confirms the favorable safety profile and the dose-dependent immune response against Clostridioides difficile bacteria and spores Allschwil, Switzerland - June 1, 2026Idorsia Ltd (SIX ...